nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—ABCB1—peripheral nervous system neoplasm	0.536	1	CbGaD
Estriol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0569	0.239	CbGbCtD
Estriol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0569	0.239	CbGbCtD
Estriol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0395	0.166	CbGbCtD
Estriol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0243	0.102	CbGbCtD
Estriol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0227	0.0953	CbGbCtD
Estriol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0223	0.0937	CbGbCtD
Estriol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0152	0.0639	CbGbCtD
Estriol—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.00222	0.176	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000648	0.0513	CbGpPWpGaD
Estriol—Estramustine—ABCB1—peripheral nervous system neoplasm	0.000587	0.333	CrCbGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000346	0.0274	CbGpPWpGaD
Estriol—Ethinyl Estradiol—ABCB1—peripheral nervous system neoplasm	0.000345	0.196	CrCbGaD
Estriol—ESR1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00034	0.0269	CbGpPWpGaD
Estriol—Abnormal vision—Epirubicin—peripheral nervous system neoplasm	0.000335	0.00158	CcSEcCtD
Estriol—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000331	0.00156	CcSEcCtD
Estriol—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00156	CcSEcCtD
Estriol—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00033	0.00156	CcSEcCtD
Estriol—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000329	0.00155	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.000328	0.026	CbGpPWpGaD
Estriol—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000328	0.00155	CcSEcCtD
Estriol—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000328	0.00155	CcSEcCtD
Estriol—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000326	0.00154	CcSEcCtD
Estriol—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000326	0.00154	CcSEcCtD
Estriol—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000326	0.00154	CcSEcCtD
Estriol—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.00154	CcSEcCtD
Estriol—ESR1—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.000325	0.0258	CbGpPWpGaD
Estriol—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.00153	CcSEcCtD
Estriol—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000325	0.00153	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00153	CcSEcCtD
Estriol—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000324	0.00153	CcSEcCtD
Estriol—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00152	CcSEcCtD
Estriol—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00152	CcSEcCtD
Estriol—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000321	0.00151	CcSEcCtD
Estriol—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.00151	CcSEcCtD
Estriol—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000319	0.0015	CcSEcCtD
Estriol—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000319	0.0015	CcSEcCtD
Estriol—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000314	0.00148	CcSEcCtD
Estriol—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.00147	CcSEcCtD
Estriol—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.00147	CcSEcCtD
Estriol—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000312	0.00147	CcSEcCtD
Estriol—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000311	0.00147	CcSEcCtD
Estriol—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.00146	CcSEcCtD
Estriol—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00031	0.00146	CcSEcCtD
Estriol—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00146	CcSEcCtD
Estriol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00145	CcSEcCtD
Estriol—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00145	CcSEcCtD
Estriol—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.00145	CcSEcCtD
Estriol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000306	0.00144	CcSEcCtD
Estriol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000304	0.00143	CcSEcCtD
Estriol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000304	0.00143	CcSEcCtD
Estriol—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.00143	CcSEcCtD
Estriol—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000304	0.00143	CcSEcCtD
Estriol—Oedema—Vincristine—peripheral nervous system neoplasm	0.000301	0.00142	CcSEcCtD
Estriol—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000301	0.00142	CcSEcCtD
Estriol—Conjugated Estrogens—ABCB1—peripheral nervous system neoplasm	0.000301	0.171	CrCbGaD
Estriol—Estrone—ABCB1—peripheral nervous system neoplasm	0.0003	0.171	CrCbGaD
Estriol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0003	0.00141	CcSEcCtD
Estriol—Infection—Vincristine—peripheral nervous system neoplasm	0.000299	0.00141	CcSEcCtD
Estriol—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.0014	CcSEcCtD
Estriol—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000296	0.00139	CcSEcCtD
Estriol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000294	0.00139	CcSEcCtD
Estriol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000292	0.00138	CcSEcCtD
Estriol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000292	0.00138	CcSEcCtD
Estriol—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.00029	0.023	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000289	0.0229	CbGpPWpGaD
Estriol—Back pain—Etoposide—peripheral nervous system neoplasm	0.000289	0.00136	CcSEcCtD
Estriol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000288	0.00136	CcSEcCtD
Estriol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000288	0.00136	CcSEcCtD
Estriol—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00136	CcSEcCtD
Estriol—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000288	0.00136	CcSEcCtD
Estriol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000285	0.00134	CcSEcCtD
Estriol—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000284	0.00134	CcSEcCtD
Estriol—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00134	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000283	0.0224	CbGpPWpGaD
Estriol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.00133	CcSEcCtD
Estriol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00133	CcSEcCtD
Estriol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00133	CcSEcCtD
Estriol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000279	0.00131	CcSEcCtD
Estriol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000277	0.00131	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000276	0.0013	CcSEcCtD
Estriol—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.0013	CcSEcCtD
Estriol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.0013	CcSEcCtD
Estriol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000275	0.0013	CcSEcCtD
Estriol—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00129	CcSEcCtD
Estriol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000273	0.00129	CcSEcCtD
Estriol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000273	0.00129	CcSEcCtD
Estriol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000273	0.00128	CcSEcCtD
Estriol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00127	CcSEcCtD
Estriol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00126	CcSEcCtD
Estriol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000267	0.00126	CcSEcCtD
Estriol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000266	0.00126	CcSEcCtD
Estriol—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000266	0.00126	CcSEcCtD
Estriol—Infection—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00125	CcSEcCtD
Estriol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000264	0.00125	CcSEcCtD
Estriol—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.00124	CcSEcCtD
Estriol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000262	0.00124	CcSEcCtD
Estriol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000262	0.00124	CcSEcCtD
Estriol—Rash—Topotecan—peripheral nervous system neoplasm	0.000262	0.00124	CcSEcCtD
Estriol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000262	0.00124	CcSEcCtD
Estriol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000261	0.00123	CcSEcCtD
Estriol—Headache—Topotecan—peripheral nervous system neoplasm	0.000261	0.00123	CcSEcCtD
Estriol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.00123	CcSEcCtD
Estriol—Rash—Tretinoin—peripheral nervous system neoplasm	0.00026	0.00123	CcSEcCtD
Estriol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00026	0.00123	CcSEcCtD
Estriol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.00123	CcSEcCtD
Estriol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00026	0.00123	CcSEcCtD
Estriol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000259	0.00122	CcSEcCtD
Estriol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000259	0.00122	CcSEcCtD
Estriol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000259	0.00122	CcSEcCtD
Estriol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000259	0.00122	CcSEcCtD
Estriol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000258	0.00122	CcSEcCtD
Estriol—Pain—Vincristine—peripheral nervous system neoplasm	0.000258	0.00121	CcSEcCtD
Estriol—Rash—Melphalan—peripheral nervous system neoplasm	0.000257	0.00121	CcSEcCtD
Estriol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000257	0.00121	CcSEcCtD
Estriol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00121	CcSEcCtD
Estriol—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.0012	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000253	0.00119	CcSEcCtD
Estriol—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00119	CcSEcCtD
Estriol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000249	0.00117	CcSEcCtD
Estriol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000248	0.00117	CcSEcCtD
Estriol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.00117	CcSEcCtD
Estriol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000247	0.00116	CcSEcCtD
Estriol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000246	0.00116	CcSEcCtD
Estriol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000245	0.00116	CcSEcCtD
Estriol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000245	0.00116	CcSEcCtD
Estriol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000244	0.00115	CcSEcCtD
Estriol—Infection—Etoposide—peripheral nervous system neoplasm	0.000243	0.00114	CcSEcCtD
Estriol—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00114	CcSEcCtD
Estriol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000242	0.00114	CcSEcCtD
Estriol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00113	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—CHEK2—peripheral nervous system neoplasm	0.00024	0.019	CbGpPWpGaD
Estriol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000238	0.00112	CcSEcCtD
Estriol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000237	0.00112	CcSEcCtD
Estriol—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.0011	CcSEcCtD
Estriol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000231	0.00109	CcSEcCtD
Estriol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00023	0.00109	CcSEcCtD
Estriol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00023	0.00108	CcSEcCtD
Estriol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000228	0.00107	CcSEcCtD
Estriol—Estradiol—ABCB1—peripheral nervous system neoplasm	0.000228	0.129	CrCbGaD
Estriol—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00106	CcSEcCtD
Estriol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00105	CcSEcCtD
Estriol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000222	0.00105	CcSEcCtD
Estriol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.00104	CcSEcCtD
Estriol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00103	CcSEcCtD
Estriol—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00103	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000216	0.0171	CbGpPWpGaD
Estriol—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00101	CcSEcCtD
Estriol—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00101	CcSEcCtD
Estriol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.00101	CcSEcCtD
Estriol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00101	CcSEcCtD
Estriol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.001	CcSEcCtD
Estriol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000211	0.000993	CcSEcCtD
Estriol—Pain—Etoposide—peripheral nervous system neoplasm	0.000209	0.000984	CcSEcCtD
Estriol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.000975	CcSEcCtD
Estriol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000206	0.000972	CcSEcCtD
Estriol—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000956	CcSEcCtD
Estriol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000955	CcSEcCtD
Estriol—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000949	CcSEcCtD
Estriol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.000944	CcSEcCtD
Estriol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0002	0.000941	CcSEcCtD
Estriol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000199	0.000939	CcSEcCtD
Estriol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.000937	CcSEcCtD
Estriol—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000936	CcSEcCtD
Estriol—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000936	CcSEcCtD
Estriol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000929	CcSEcCtD
Estriol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000929	CcSEcCtD
Estriol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000196	0.000925	CcSEcCtD
Estriol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.000923	CcSEcCtD
Estriol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000194	0.000914	CcSEcCtD
Estriol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000193	0.00091	CcSEcCtD
Estriol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000192	0.000903	CcSEcCtD
Estriol—Rash—Vincristine—peripheral nervous system neoplasm	0.00019	0.000896	CcSEcCtD
Estriol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00019	0.000895	CcSEcCtD
Estriol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000894	CcSEcCtD
Estriol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000892	CcSEcCtD
Estriol—Headache—Vincristine—peripheral nervous system neoplasm	0.000189	0.00089	CcSEcCtD
Estriol—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000885	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000188	0.0149	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000187	0.0148	CbGpPWpGaD
Estriol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000876	CcSEcCtD
Estriol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000875	CcSEcCtD
Estriol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000859	CcSEcCtD
Estriol—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000858	CcSEcCtD
Estriol—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000848	CcSEcCtD
Estriol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00018	0.000848	CcSEcCtD
Estriol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000179	0.000844	CcSEcCtD
Estriol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000843	CcSEcCtD
Estriol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000828	CcSEcCtD
Estriol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000825	CcSEcCtD
Estriol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000824	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—BIRC5—peripheral nervous system neoplasm	0.000174	0.0138	CbGpPWpGaD
Estriol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00082	CcSEcCtD
Estriol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000173	0.000814	CcSEcCtD
Estriol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00081	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000171	0.0135	CbGpPWpGaD
Estriol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000802	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.00017	0.0135	CbGpPWpGaD
Estriol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000799	CcSEcCtD
Estriol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000795	CcSEcCtD
Estriol—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000794	CcSEcCtD
Estriol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000792	CcSEcCtD
Estriol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000791	CcSEcCtD
Estriol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00079	CcSEcCtD
Estriol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000167	0.000787	CcSEcCtD
Estriol—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000785	CcSEcCtD
Estriol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00078	CcSEcCtD
Estriol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000779	CcSEcCtD
Estriol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000776	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.000164	0.013	CbGpPWpGaD
Estriol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000768	CcSEcCtD
Estriol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000764	CcSEcCtD
Estriol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000762	CcSEcCtD
Estriol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000161	0.000761	CcSEcCtD
Estriol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00076	CcSEcCtD
Estriol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000759	CcSEcCtD
Estriol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000746	CcSEcCtD
Estriol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000742	CcSEcCtD
Estriol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000736	CcSEcCtD
Estriol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000155	0.000732	CcSEcCtD
Estriol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000731	CcSEcCtD
Estriol—Rash—Etoposide—peripheral nervous system neoplasm	0.000154	0.000726	CcSEcCtD
Estriol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000154	0.000725	CcSEcCtD
Estriol—Headache—Etoposide—peripheral nervous system neoplasm	0.000153	0.000721	CcSEcCtD
Estriol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000721	CcSEcCtD
Estriol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000718	CcSEcCtD
Estriol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00071	CcSEcCtD
Estriol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000707	CcSEcCtD
Estriol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000703	CcSEcCtD
Estriol—ESR1—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000148	0.0117	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.000147	0.0116	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000146	0.0116	CbGpPWpGaD
Estriol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000145	0.000683	CcSEcCtD
Estriol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000682	CcSEcCtD
Estriol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000671	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000142	0.0112	CbGpPWpGaD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000668	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000139	0.011	CbGpPWpGaD
Estriol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000645	CcSEcCtD
Estriol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000645	CcSEcCtD
Estriol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000641	CcSEcCtD
Estriol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000635	CcSEcCtD
Estriol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000633	CcSEcCtD
Estriol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000631	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000134	0.0106	CbGpPWpGaD
Estriol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000627	CcSEcCtD
Estriol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00062	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000618	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000129	0.0102	CbGpPWpGaD
Estriol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000597	CcSEcCtD
Estriol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000597	CcSEcCtD
Estriol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000593	CcSEcCtD
Estriol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000587	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000124	0.00984	CbGpPWpGaD
Estriol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000585	CcSEcCtD
Estriol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000583	CcSEcCtD
Estriol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00058	CcSEcCtD
Estriol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000568	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000118	0.00938	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000557	CcSEcCtD
Estriol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000552	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000116	0.00922	CbGpPWpGaD
Estriol—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000115	0.00914	CbGpPWpGaD
Estriol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00054	CcSEcCtD
Estriol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000527	CcSEcCtD
Estriol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000525	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000111	0.00877	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.00011	0.00869	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000515	CcSEcCtD
Estriol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000512	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000109	0.00861	CbGpPWpGaD
Estriol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00051	CcSEcCtD
Estriol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00051	CcSEcCtD
Estriol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000488	CcSEcCtD
Estriol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000475	CcSEcCtD
Estriol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000474	CcSEcCtD
Estriol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000472	CcSEcCtD
Estriol—ESR2—Gene Expression—EED—peripheral nervous system neoplasm	9.99e-05	0.00791	CbGpPWpGaD
Estriol—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000456	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	9.65e-05	0.00765	CbGpPWpGaD
Estriol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.000441	CcSEcCtD
Estriol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.00044	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	9.21e-05	0.00729	CbGpPWpGaD
Estriol—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000427	CcSEcCtD
Estriol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000422	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	8.78e-05	0.00696	CbGpPWpGaD
Estriol—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	8.78e-05	0.00696	CbGpPWpGaD
Estriol—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.00041	CcSEcCtD
Estriol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000408	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	8.63e-05	0.00684	CbGpPWpGaD
Estriol—Rash—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000407	CcSEcCtD
Estriol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000406	CcSEcCtD
Estriol—Headache—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000404	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	8.56e-05	0.00678	CbGpPWpGaD
Estriol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000395	CcSEcCtD
Estriol—Nausea—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000383	CcSEcCtD
Estriol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000379	CcSEcCtD
Estriol—ESR2—Gene Expression—SUZ12—peripheral nervous system neoplasm	7.99e-05	0.00633	CbGpPWpGaD
Estriol—Rash—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000376	CcSEcCtD
Estriol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000376	CcSEcCtD
Estriol—Headache—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000374	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	7.82e-05	0.0062	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	7.81e-05	0.00619	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	7.72e-05	0.00612	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	7.68e-05	0.00608	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	7.67e-05	0.00608	CbGpPWpGaD
Estriol—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000354	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	7.43e-05	0.00589	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	7.27e-05	0.00576	CbGpPWpGaD
Estriol—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.18e-05	0.00569	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.17e-05	0.00568	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.15e-05	0.00567	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	6.95e-05	0.00551	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	6.94e-05	0.0055	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.9e-05	0.00546	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	6.52e-05	0.00517	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	6.52e-05	0.00516	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	6.3e-05	0.00499	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	6.26e-05	0.00496	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	5.97e-05	0.00473	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.91e-05	0.00469	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	5.87e-05	0.00465	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	5.71e-05	0.00453	CbGpPWpGaD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	5.58e-05	0.00442	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	5.53e-05	0.00438	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	5.32e-05	0.00421	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	5.2e-05	0.00412	CbGpPWpGaD
Estriol—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	5.04e-05	0.00399	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	4.99e-05	0.00395	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.84e-05	0.00383	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	4.63e-05	0.00366	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.62e-05	0.00366	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	4.27e-05	0.00338	CbGpPWpGaD
Estriol—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	4.03e-05	0.00319	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.02e-05	0.00319	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	3.94e-05	0.00313	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	3.86e-05	0.00306	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.79e-05	0.003	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.78e-05	0.003	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	3.69e-05	0.00292	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.66e-05	0.0029	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.65e-05	0.00289	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.6e-05	0.00285	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.5e-05	0.00277	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.45e-05	0.00273	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	3.41e-05	0.0027	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.36e-05	0.00266	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.29e-05	0.0026	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.23e-05	0.00256	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	3.21e-05	0.00254	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.2e-05	0.00254	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.2e-05	0.00253	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.16e-05	0.0025	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.07e-05	0.00243	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	3e-05	0.00238	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.98e-05	0.00236	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.95e-05	0.00234	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.94e-05	0.00233	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.88e-05	0.00228	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	2.81e-05	0.00223	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.37e-05	0.00188	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.33e-05	0.00184	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	2.31e-05	0.00183	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.29e-05	0.00182	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.27e-05	0.0018	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	2.2e-05	0.00174	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.12e-05	0.00168	CbGpPWpGaD
Estriol—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.07e-05	0.00164	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2e-05	0.00158	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.95e-05	0.00154	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	1.94e-05	0.00154	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.91e-05	0.00152	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.79e-05	0.00142	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.79e-05	0.00142	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.74e-05	0.00138	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.71e-05	0.00135	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.68e-05	0.00133	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.66e-05	0.00131	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.61e-05	0.00128	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.58e-05	0.00125	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.56e-05	0.00124	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.5e-05	0.00119	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.44e-05	0.00114	CbGpPWpGaD
Estriol—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.38e-05	0.0011	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.38e-05	0.00109	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.35e-05	0.00107	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000996	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.24e-05	0.000985	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.23e-05	0.000976	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.16e-05	0.000916	CbGpPWpGaD
Estriol—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	1.1e-05	0.000875	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.06e-05	0.000843	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.01e-05	0.000803	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.01e-05	0.000802	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.3e-06	0.000737	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.08e-06	0.000719	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.54e-06	0.000677	CbGpPWpGaD
Estriol—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.67e-06	0.000608	CbGpPWpGaD
Estriol—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	7.66e-06	0.000607	CbGpPWpGaD
Estriol—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.32e-06	0.00058	CbGpPWpGaD
Estriol—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.21e-06	0.000571	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.47e-06	0.000512	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.89e-06	0.000466	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	5.57e-06	0.000441	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.11e-06	0.000405	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.64e-06	0.000367	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.89e-06	0.000308	CbGpPWpGaD
Estriol—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.86e-06	0.000306	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.71e-06	0.000294	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.62e-06	0.000287	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.97e-06	0.000236	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.84e-06	0.000225	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.51e-06	0.000199	CbGpPWpGaD
Estriol—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-06	0.000126	CbGpPWpGaD
